MSD Pharmaceuticals, a wholly-owned subsidiary of Merck Sharp & Dohme, launched India’s first gender neutral HPV vaccine Gardasil 9. This nine-valent Human Papillomavirus vaccine would work against nine variants of HPV and is for use in girls (9- to 26-year-old) and boys (9-15-year-old).
HPV is responsible for causing cervical cancer, which can be detected through a simple screening procedure called the pap smear test. Boys also need to be vaccinated as they are often carriers of HPV.
Rehan A Khan, Managing Director, MSD-India Region said that the vaccine will be imported into the country. “There is a large cohort of

)